The pathophysiology of chronic cardiorenal disease based on central hemodynamics
Main Article Content
Abstract
As patients with chronic kidney disease (CKD) and chronic heart failure (CHF) increase, there is concern about a future heart failure pandemic. Deterioration of renal function is an independent prognostic factor for CHF after decongestion. Interactions between renal disease and cardiac disease are increasing, including nephrosclerosis and heart failure with preserved ejection fraction (HFpEF), which are both derived from augmentation of central pulse pressure by age-related arterial stiffening. Thus, it is necessary to treat multiple underlying diseases of cardiorenal syndrome simultaneously. However, an effective therapeutic strategy for HFpEF has not been established. This review reconsiders the pathophysiology of chronic cardiorenal disease related to arterial stiffening from the viewpoint of central hemodynamics and explores treatment options.
Downloads
Article Details
Copyright (c) 2018 Ohno M.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Wang KL, Cheng HM, Chuang SY, Spurgeon HA, Ting CT, et al. [2009] Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality? J Hypertens 27: 461-467. Link: https://tinyurl.com/ycb8bm29
Hashimoto J, Imai Y, O'Rourke MF [2007] Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure. Am J Hypertens 20: 378-384. Link: https://tinyurl.com/ycycsew8
Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, et al. [2010] Perumal K, Lash JP, Chen J, Steigerwalt SP, Flack J, Go AS, Rafey M, Rahman M, Sheridan A, Gadegbeku CA, Robinson NA, Joffe M. Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens 23: 282-289. Link: https://tinyurl.com/ydcvyf6t
Hashimoto J, Ito S [2011] Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension. Hypertension 58: 839-846. Link: https://tinyurl.com/y9dkl7pc
Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, et al. [2006] Collier D, Hughes AD, Thurston H, O'Rourke M; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation [CAFE] study. Circulation 113: 1213-1225. Link: https://tinyurl.com/yd24nlmm
Pini R, Cavallini MC, Palmieri V, Marchionni N, Di Bari M, et al. [2008] Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol 51: 2432-2439. Link: https://tinyurl.com/y785vly2
Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, et al. [2007] Ali T, Umans JG, Howard BV. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 50: 197-203. Link: https://tinyurl.com/y7nl4ekz
Tomiyama H, O'rourke MF, Hashimoto H, Matsumoto C, Odaira M, et al. [2013] Yoshida M, Shiina K, Nagata M, Yamashina A. Central blood pressure: a powerful predictor of the development of hypertension. Hypertens Res 36: 19-24. Link: https://tinyurl.com/yaw2tcpt
Bristow MR, Lowes BD [2005] Management of heart failure. In: Zipes DP eds. Braunwald’s Heart Disease. A Textbook of Cardiovascular Medicine, 7th ed. Philadelphia: Elsevier Sunders 603-624.
Okura Y, Ramadan MM, Ohno Y, Mitsuma W, Tanaka K, et al. [2008] Ito M, Suzuki K, Tanabe N, Kodama M, Aizawa Y. Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J 72: 489-491. Link: https://tinyurl.com/yazte4hf
Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, et al. [1999] Hofman A, Grobbee DE. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 20: 447-455. Link:
Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, et al. [2003] Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289: 194-202. Link: https://tinyurl.com/y7vzj23r
Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, et al. [2004] Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 25: 1614-1619. Link: https://tinyurl.com/ycpoa9o3
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, et al. [2006] Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355: 251-259. Link: https://tinyurl.com/y9ugklqh
Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, et al. [2000] Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102: 203-210. Link: https://tinyurl.com/y8ns589q
Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, et al. [2006] Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity [CHARM] Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113: 671-678. Link: https://tinyurl.com/y9e4vm6l
van Kimmenade RR, Januzzi JL Jr, Baggish AL, Lainchbury JG, Bayes-Genis A, et al. [2006] Richards AM, Pinto YM. Amino-terminal pro-brain natriuretic Peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? J Am Coll Cardiol 48:1621-1627. Link: https://tinyurl.com/ydb4ed3h
Foley RN, Collins AJ [2013] The USRDS: what you need to know about what it can and can't tell us about ESRD. Clin J Am Soc Nephrol 8: 845-851. Link: https://tinyurl.com/y9wjyvno
Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, et al. [2015] Hamano T, Wakai K, Wada A, Nitta K. An Overview of Regular Dialysis Treatment in Japan [As of 31 December 2013]. Ther Apher Dial 19: 540-574. Link: https://tinyurl.com/y9b97ak9
KDOQI [2007] KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 49: S12-154. Link: https://tinyurl.com/ybyucwab
de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, et al. [2013] BEACON Trial Investigators. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 369: 2492-2503. Link: https://tinyurl.com/y7e5dg3h
Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, et al. [2014] Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis 64: 510-533. Link: https://tinyurl.com/y8y6pp46
Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, et al. [2016] Weiss NS, de Boer IH. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014. JAMA 316: 602-610. Link: https://tinyurl.com/y73ddets
Ronco C, House AA, Haapio M [2008] Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med 34: 957-962. Link: https://tinyurl.com/ycgj89vc
Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, et al. [2004] Massie BM, O'Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147: 331-338. Link: https://tinyurl.com/yb328blj
Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B [2006] POSH Investigators. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure [POSH]. Eur Heart J 27: 1216-1222. Link: https://tinyurl.com/yda8kr9k
Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, et al. [2007] Cleland JG, van Veldhuisen DJ, Hillege HL. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 13: 599-608. Link: https://tinyurl.com/yaa38dgf
Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, et al. [2004] Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43: 61-67. Link: https://tinyurl.com/ycdaz778
O'Rourke MF, Hashimoto J [2007] Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 50: 1-13. Link: https://tinyurl.com/y8yussjp
Torjesen AA, Wang N, Larson MG, Hamburg NM, Vita JA, et al. [2014] Levy D, Benjamin EJ, Vasan RS, Mitchell GF. Forward and backward wave morphology and central pressure augmentation in men and women in the Framingham Heart Study. Hypertension. 64:259-65. Link: https://tinyurl.com/ybkxpfu6
Tomiyama H, Yamashina A [2010] Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J 74: 24-33. Link: https://tinyurl.com/y8q89yup
Hashimoto J, Ito S [2014] Central pulse pressure links microalbuminuria with plasma B-type natriuretic peptide elevation: causal implication for cardiorenal syndrome in hypertension. J Hypertens 32: 1665-1671. Link: https://tinyurl.com/y9pxuc8n
Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, et al. [2009] Wang W, Umans JG, Calhoun D, Howard BV. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol 54: 1730-1734. Link: https://tinyurl.com/y8t23p9v
Agabiti-Rosei E, Mancia G, O'Rourke MF, Roman MJ, Safar ME, et al. [2007] Smulyan H, Wang JG, Wilkinson IB, Williams B, Vlachopoulos C. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 50: 154-160. Link: https://tinyurl.com/yd7axlbd
McEniery CM, Yasmin, McDonnell B, Munnery M, Wallace SM, et al. [2008] Rowe CV, Cockcroft JR, Wilkinson IB; Anglo-Cardiff Collaborative Trial Investigators. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension 51: 1476-1482. Link: https://tinyurl.com/y82qlhan
O'Rourke MF, Safar ME [2005] Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 46: 200-204. Link: https://tinyurl.com/yab8qmxu
Munakata M, Nunokawa T, Yoshinaga K, Toyota T [2006] J-TOPP Study Group. Brachial-ankle pulse wave velocity is an independent risk factor for microalbuminuria in patients with essential hypertension--a Japanese trial on the prognostic implication of pulse wave velocity [J-TOPP]. Hypertens Res 29: 515-521. Link: https://tinyurl.com/y7e4pw2n
Taal MW, Sigrist MK, Fakis A, Fluck RJ, McIntyre CW [2007] Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5. Nephron Clin Pract 107: 177-181. Link: https://tinyurl.com/y79fuwxe
Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, et al. [2001] Gebel MJ, Galanski M, Koch KM, Haller H. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 344: 410-417. Link: https://tinyurl.com/yaa27v5a
Radermacher J, Ellis S, Haller H [2002] Renal resistance index and progression of renal disease. Hypertension 39: 699-703. Link: https://tinyurl.com/y7bcgaor
Radermacher J, Mengel M, Ellis S, Stuht S, Hiss M, et al. [2003] Schwarz A, Eisenberger U, Burg M, Luft FC, Gwinner W, Haller H. The renal arterial resistance index and renal allograft survival. N Engl J Med 349: 115-124. Link: https://tinyurl.com/y8fwx9wb
Nosadini R, Velussi M, Brocco E, Abaterusso C, Carraro A, et al. [2006] Piarulli F, Morgia G, Satta A, Faedda R, Abhyankar A, Luthman H, Tonolo G. Increased renal arterial resistance predicts the course of renal function in type 2 diabetes with microalbuminuria. Diabetes 55: 234-239. Link: https://tinyurl.com/y8j7tyay
Okura T, Kurata M, Irita J, Enomoto D, Jotoku M, et al. [2010] Nagao T, Koresawa M, Kojima S, Hamano Y, Mashiba S, Miyoshi K, Higaki J. Renal resistance index is a marker of future renal dysfunction in patients with essential hypertension. J Nephrol 23: 175-180. Link: https://tinyurl.com/y9zfwwyx
Ikee R, Kobayashi S, Hemmi N, Imakiire T, Kikuchi Y, et al. [2005] Moriya H, Suzuki S, Miura S. Correlation between the resistive index by Doppler ultrasound and kidney function and histology. Am J Kidney Dis 46: 603-609. Link: https://tinyurl.com/y73x64rs
Pontremoli R, Viazzi F, Martinoli C, Ravera M, Nicolella C, et al. [1999] Berruti V, Leoncini G, Ruello N, Zagami P, Bezante GP, Derchi LE, Deferrari G. Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. Nephrol Dial Transplant 14: 360-365. Link: https://tinyurl.com/y96nrorn
Hamano K, Nitta A, Ohtake T, Kobayashi S [2008] Associations of renal vascular resistance with albuminuria and other macroangiopathy in type 2 diabetic patients. Diabetes Care 31: 1853-1857. Link: https://tinyurl.com/y9wbfxua
Dworkin LD, Brenner BM [2004] The renal circulation. In: Brenner BM, Editor. Brenner & Rector's The Kidney, 7th ed. Philadelphia: W. B. Saunders 309-352.
Kelly RP, Gibbs HH, O'Rourke MF, Daley JE, Mang K, et al. [1990] Morgan JJ, Avolio AP. Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J. 11:138-44. Link: https://tinyurl.com/ycv3djhc
Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Miyashita H, et al. [2009] Shimada K, Kario K. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension 54: 716-723. Link: https://tinyurl.com/ybhgqonm
Miyashita H, Aizawa A, Hashimoto J, Hirooka Y, Imai Y, et al [2010] Kawano Y, Kohara K, Sunagawa K, Suzuki H, Tabara Y, Takazawa K, Takenaka T, Yasuda H, Shimada K. Cross-sectional characterization of all classes of antihypertensives in terms of central blood pressure in Japanese hypertensive patients. Am J Hypertens. 23: 260-268. Link: https://tinyurl.com/y8l6hmt4
Boutouyrie P, Bussy C, Hayoz D, Hengstler J, Dartois N, et al. [2000] Laloux B, Brunner H, Laurent S. Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation 101: 2601-2606. Link: https://tinyurl.com/ybvwurua
Cheng HM, Chuang SY, Sung SH, Yu WC, Pearson A, et al. [2013] Lakatta EG, Pan WH, Chen CH. Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-term cardiovascular risks. J Am Coll Cardiol 62: 1780-1787. Link: https://tinyurl.com/ydhdmp2f
Sharman JE, Marwick TH, Gilroy D, Otahal P, Abhayaratna WP, et al. [2013] Stowasser M; Value of Central Blood Pressure for GUIDing ManagEment of Hypertension Study Investigators. Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the BP GUIDE study. Hypertension 62: 1138-1145. Link: https://tinyurl.com/y94tcmvx
Ho JE, Enserro D, Brouwers FP, Kizer JR, Shah SJ, et al. [2016] Psaty BM, Bartz TM, Santhanakrishnan R, Lee DS, Chan C, Liu K, Blaha MJ, Hillege HL, van der Harst P, van Gilst WH, Kop WJ, Gansevoort RT, Vasan RS, Gardin JM, Levy D, Gottdiener JS, de Boer RA, Larson MG. Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes. Circ Heart Fail 9: 003116. Link: https://tinyurl.com/y7ffel8r
Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S, Goto D, Takeshita A [2006] JCARE-CARD Investigators. Clinical characteristics and outcome of hospitalized patients with heart failure in Japan. Circ J 70: 1617-1623. Link: https://tinyurl.com/ycws3fe3
Kawaguchi M, Hay I, Fetics B, Kass DA [2003] Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 107: 714-720. Link: https://tinyurl.com/y9yq8kbx
Kass DA [2005] Ventricular arterial stiffening: integrating the pathophysiology. Hypertension 46: 85-193. Link: https://tinyurl.com/y7vbupfk
Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA [2005] Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 112: 2254-2262. Link: https://tinyurl.com/ybmzexbv
Cheng CP, Noda T, Nozawa T, Little WC [1993] Effect of heart failure on the mechanism of exercise-induced augmentation of mitral valve flow. Circ Res 72: 795-806. Link: https://tinyurl.com/yan8waae
Ohno M, Cheng CP, Little WC [1994] Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 89: 2241-2250. Link: https://tinyurl.com/y8b9wrc8
Maeder MT, Kaye DM [2009] Heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol 53: 905-918. Link: https://tinyurl.com/y6u9mnuj
Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, et al. [2007] How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28: 2539-2550. Link: https://tinyurl.com/y7n2946o
Maurer MS, King DL, El-Khoury Rumbarger L, Packer M, Burkhoff D [2005] Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J Card Fail 11: 177-187. Link: https://tinyurl.com/yb7lcbqj
Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, et al. [2008] Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Stevenson LW, Kueffer FJ, Bourge RC. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 118: 1433-1441. Link: https://tinyurl.com/y86cokv6
Anjan VY, Loftus TM, Burke MA, Akhter N, Fonarow GC, et al. [2012] Gheorghiade M, Shah SJ. Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction. Am J Cardiol 110: 870-876. Link: https://tinyurl.com/ybnfnbwo
Redfield MM [2016] Heart Failure with Preserved Ejection Fraction. N Engl J Med 375: 1868-1877. Link: https://tinyurl.com/yd83r3lx
Bishu K, Deswal A, Chen HH, LeWinter MM, Lewis GD, et al. [2012] Semigran MJ, Borlaug BA, McNulty S, Hernandez AF, Braunwald E, Redfield MM. Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. Am Heart J 164: 763-770. Link: https://tinyurl.com/ybelqozp
Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM [2010] Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 3: 588-55. Link: https://tinyurl.com/yaflldp2
Hogg K, Swedberg K, McMurray J [2004] Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43: 317-327. Link: https://tinyurl.com/y8j3vzhb
Antonini-Canterin F, Carerj S, Di Bello V, Di Salvo G, La Carrubba S, et al. [2009] Vriz O, Pavan D, Balbarini A, Nicolosi GL; Research Group of the Italian Society of Cardiovascular Echography [SIEC]. Arterial stiffness and ventricular stiffness: a couple of diseases or a coupling disease? A review from the cardiologist's point of view. Eur J Echocardiogr 10: 36-43. Link: https://tinyurl.com/yayoov6b
Chen CH, Nakayama M, Nevo E, Fetics BJ, Maughan WL, et al. [1998] Kass DA. Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol 32: 1221-1227. Link: https://tinyurl.com/ydxzy93v
Burkhoff D, Maurer MS, Packer M [2003] Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation 107: 656-658. Link: https://tinyurl.com/yab4z85j
Quinones MA, Gaasch WH, Alexander JK [1976] Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumic indices of myocardial contractility in man. Circulation 53: 293-302. Link: https://tinyurl.com/ybsbh4oc
Ross J Jr [1976] Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 18: 255-264. Link: https://tinyurl.com/yb3qjuuk
Donal E, Bergerot C, Thibault H, Ernande L, Loufoua J, et al. [2009] Augeul L, Ovize M, Derumeaux G. Influence of afterload on left ventricular radial and longitudinal systolic functions: a two-dimensional strain imaging study Eur J Echocardiogr 10: 914-921. Link: https://tinyurl.com/y9sdhlpq
Borlaug BA, Melenovsky V, Redfield MM, Kessler K, Chang HJ, Abraham TP, et al. [2007] Kass DA. Impact of arterial load and loading sequence on left ventricular tissue velocities in humans. J Am Coll Cardiol 50: 1570-1577. Link: https://tinyurl.com/ycrabn7h
Fujimoto N, Onishi K, Dohi K, Tanabe M, Kurita T, Takamura T, et al. [2008] Yamada N, Nobori T, Ito M. Hemodynamic characteristics of patients with diastolic heart failure and hypertension. Hypertens Res 31: 1727-1735. Link: https://tinyurl.com/yc4hbmy8
Robotham JL, Takata M, Berman M, Harasawa Y [1991] Ejection fraction revisited. Anesthesiology 74: 172-183. Link: https://tinyurl.com/yd3rmhvq
Borlaug BA, Kass DA [2008] Ventricular-vascular interaction in heart failure. Heart Fail Clin 4: 23-36. Link: https://tinyurl.com/yccqznsk
Borlaug BA, Lam CS, Roger VL, Rodeheffer RJ, Redfield MM [2009] Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol 54: 410-418. Link: https://tinyurl.com/yavg32a3
Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ [1991] Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 17: 1065-1072. Link: https://tinyurl.com/y7qllbnu
Metra M, Teerlink JR [2017] Heart failure. Lancet 390: 1981-1995. Link: https://tinyurl.com/y8tmswum
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. [2013] 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128: 1810-1852. Link: https://tinyurl.com/yd2thxew
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, et al. [2016] Authors/Task Force Members; Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology [ESC]. Developed with the special contribution of the Heart Failure Association [HFA] of the ESC. Eur J Heart Fail 18: 891-975. Link: https://tinyurl.com/y7txtkj3
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, et al. [2016] 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 134: 282-293. Link: https://tinyurl.com/yahka2b5
Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, et al [2009] Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53: 589-596. Link: https://tinyurl.com/yaewba4q
Dupont M, Mullens W, Tang WH [2011] Impact of systemic venous congestion in heart failure. Curr Heart Fail Rep 8: 233-241. Link: https://tinyurl.com/y8xgtvmy
Ross EA [2012] Congestive renal failure: the pathophysiology and treatment of renal venous hypertension. J Card Fail 18: 930-938. Link: https://tinyurl.com/y7cwkfqr
Gheorghiade M, De Luca L, Fonarow GC, Filippatos G, Metra M, et al. [2005] Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol 96: 11-17. Link: https://tinyurl.com/y84mpunr
Ambrosy A, Goldsmith SR, Gheorghiade M [2011] Tolvaptan for the treatment of heart failure: a review of the literature. Expert Opin Pharmacother 12: 961-976. Link: https://tinyurl.com/ycsz25fr
Costello-Boerrigter LC, Smith WB, Boerrigter G, Ouyang J, Zimmer CA, et al. [2006] Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. Am J Physiol Renal Physiol 290: 273-278. Link: https://tinyurl.com/ycsz25fr
Smith GL, Vaccarino V, Kosiborod M, Lichtman JH, Cheng S, et al. [2003] Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 9: 13-25. Link: https://tinyurl.com/ya56h2ob
de Silva R, Nikitin NP, Witte KK, Rigby AS, Goode K, et al. [2006] Bhandari S, Clark AL, Cleland JG. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 27: 569-581. Link: https://tinyurl.com/yc267vuj
Damman K, Valente MA, Voors AA, O'Connor CM, van Veldhuisen DJ, et al . [2014] Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35: 455-469. Link: https://tinyurl.com/y9cozo3h